Chemotherapy for breast cancer: cycles, timing and side effects

Most people having chemotherapy for early breast cancer receive somewhere between four and eight cycles, spread over roughly three to six months. A cycle is a treatment day followed by rest, usually every two or three weeks, though some medicines are given weekly. Many plans use two groups of medicines one after the other, so the course has two parts. The exact number depends on the size of the tumour, whether glands under the arm are involved, the tissue markers and your general health. For breast cancer that has spread, chemotherapy is planned differently and may continue while it is helping. Your oncologist will explain your own schedule before you start.

Chemotherapy can be given before surgery, after surgery, or occasionally both. Giving it first is common when the tumour is large, when glands are involved, or when the cancer is triple-negative or driven by an extra growth protein. Treatment first can shrink the tumour, sometimes allowing the breast to be kept, and shows how the cancer responds. If some cancer remains at surgery, further treatment may be offered afterwards. When surgery comes first, chemotherapy follows if the tissue report shows a higher chance of the cancer coming back. Radiotherapy, hormone tablets or targeted medicines often come later in the plan, and your oncologist will explain why this particular order has been chosen for you and your family.

Side effects depend on the medicines chosen, but some are typical of breast cancer courses. Hair loss is common with many schedules and usually begins a few weeks after the first cycle. Tiredness, feeling sick, mouth soreness, taste changes, nail changes and a lower resistance to infection are frequent. Tingling or numbness in the fingers and toes can build up with certain medicines. Periods often become irregular or stop, and some women go through an early menopause, which matters if you hope to have children. Most effects settle after treatment ends, and your team will give medicines and practical advice to ease them. Always report new or worsening effects rather than waiting for your next appointment.

Usually a few months of cycles

Commonly four to eight cycles over three to six months.

Before or after surgery

The tumour size, glands and tissue markers guide the order.

Side effects are mostly temporary

Hair loss, tiredness and infection risk are the common ones.

It cannot tell you whether you need chemotherapy or how many cycles are right for you. Your reports decide that.

It also cannot predict your side effects. Your team will explain what is likely with your own medicines.

Why tissue markers matter

The tissue sample is tested for hormone sensitivity and for an extra growth protein on the cancer cells. These markers decide whether chemotherapy is useful, which medicines are chosen and whether hormone or targeted treatment is added. Keep a copy of this report with you.

Hormone-sensitive cancers

When cancer grows in response to hormones, hormone tablets are often the main long-term treatment. Chemotherapy may be added if the tumour is larger, glands are involved or gene tests suggest a higher chance of the cancer coming back. Many people in this group do not need it.

Cancers driven by a growth protein

When the cancer cells carry an extra growth protein, targeted medicines are usually given with or after chemotherapy. These often continue for several months after chemotherapy finishes and need regular heart checks. Your oncologist will explain how long this part of the plan lasts and how it is given.

Triple-negative cancers

These cancers are not driven by hormones or the growth protein, so chemotherapy is often the main medicine treatment. It is frequently given before surgery. Immunotherapy is sometimes added. Your team will explain whether this applies to you and what it involves, including any extra checks or side effects to watch for.

Gene tests on the tumour

For some early hormone-sensitive cancers, a gene test on the tumour tissue estimates the chance of the cancer coming back and whether chemotherapy would add benefit. These tests are not needed for everyone and have a cost. Ask whether one would actually change your plan before paying for it.

Scalp cooling

A cold cap worn during the infusion can reduce hair loss for some people on some medicines. It is not available in every unit, adds time to each visit and does not suit every schedule. Ask whether it is offered at your centre and suitable for your medicines.

Fertility and pregnancy

Chemotherapy can reduce fertility. If you may want children, ask about egg or embryo storage before the first cycle. Pregnancy should be avoided during treatment, so ask your team which contraception is suitable, as some hormone-based methods may not be advised after breast cancer. Your team can guide you.

Younger women

Younger women may worry about work, young children, body image and early menopause. These concerns are valid and worth raising. Counsellors, breast care nurses and support groups can help you and your family plan practical and emotional support during treatment and through the months of recovery after it ends.

Older women

Age alone does not decide whether chemotherapy is offered. Fitness, heart and kidney function, other illnesses and personal wishes all matter. Schedules can be adjusted, and some older women with lower-risk cancers may be well served without chemotherapy, relying instead on surgery, radiotherapy and hormone tablets as advised.

Heart and blood checks

Some breast cancer medicines can affect the heart, so a heart scan may be done before and during treatment. Blood tests before each cycle check counts, liver and kidney function. These checks are routine and help keep treatment safe. Tell your team about any existing heart condition or blood pressure medicines.

Working through treatment

Some people keep working with adjusted hours, especially on weekly schedules. Others need time off after each cycle. Planning around the days you feel most tired, and telling your employer what you are comfortable sharing, often helps. Some employers allow flexible hours or working from home during the course of treatment.

Costs and planning

The cost of a breast cancer course depends on the medicines, the number of cycles, targeted treatment, supportive medicines and scans. Targeted medicines add considerably to cost. Ask for a written estimate covering the whole plan, not just the first cycle, and ask about insurance or government scheme coverage.

What to do next

Get copies of your tissue sample report and scans, ask how many cycles are planned and in what order, discuss fertility before starting, and keep your team's emergency number with you at all times.